Cargando…

A novel spray-dried nanoparticles-in-microparticles system for formulating scopolamine hydrobromide into orally disintegrating tablets

Scopolamine hydrobromide (SH)-loaded microparticles were prepared from a colloidal fluid containing ionotropic-gelated chitosan nanoparticles using a spray-drying method. The spray-dried microparticles were then formulated into orally disintegrating tablets (ODTs) using a wet granulation tablet form...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Feng-Qian, Yan, Cheng, Bi, Juan, Lv, Wei-Lin, Ji, Rui-Rui, Chen, Xu, Su, Jia-Can, Hu, Jin-Hong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3124395/
https://www.ncbi.nlm.nih.gov/pubmed/21720502
http://dx.doi.org/10.2147/IJN.S17900
_version_ 1782207079991214080
author Li, Feng-Qian
Yan, Cheng
Bi, Juan
Lv, Wei-Lin
Ji, Rui-Rui
Chen, Xu
Su, Jia-Can
Hu, Jin-Hong
author_facet Li, Feng-Qian
Yan, Cheng
Bi, Juan
Lv, Wei-Lin
Ji, Rui-Rui
Chen, Xu
Su, Jia-Can
Hu, Jin-Hong
author_sort Li, Feng-Qian
collection PubMed
description Scopolamine hydrobromide (SH)-loaded microparticles were prepared from a colloidal fluid containing ionotropic-gelated chitosan nanoparticles using a spray-drying method. The spray-dried microparticles were then formulated into orally disintegrating tablets (ODTs) using a wet granulation tablet formation process. A drug entrapment efficiency of about 90% (w/w) and loading capacity of 20% (w/w) were achieved for the microparticles, which ranged from 2 μm to 8 μm in diameter. Results of disintegration tests showed that the formulated ODTs could be completely dissolved within 45 seconds. Drug dissolution profiles suggested that SH is released more slowly from tablets made using the microencapsulation process compared with tablets containing SH that is free or in the form of nanoparticles. The time it took for 90% of the drug to be released increased significantly from 3 minutes for conventional ODTs to 90 minutes for ODTs with crosslinked microparticles. Compared with ODTs made with noncrosslinked microparticles, it was thus possible to achieve an even lower drug release rate using tablets with appropriate chitosan crosslinking. Results obtained indicate that the development of new ODTs designed with crosslinked microparticles might be a rational way to overcome the unwanted taste of conventional ODTs and the side effects related to SH’s intrinsic characteristics.
format Online
Article
Text
id pubmed-3124395
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher Dove Medical Press
record_format MEDLINE/PubMed
spelling pubmed-31243952011-06-29 A novel spray-dried nanoparticles-in-microparticles system for formulating scopolamine hydrobromide into orally disintegrating tablets Li, Feng-Qian Yan, Cheng Bi, Juan Lv, Wei-Lin Ji, Rui-Rui Chen, Xu Su, Jia-Can Hu, Jin-Hong Int J Nanomedicine Original Research Scopolamine hydrobromide (SH)-loaded microparticles were prepared from a colloidal fluid containing ionotropic-gelated chitosan nanoparticles using a spray-drying method. The spray-dried microparticles were then formulated into orally disintegrating tablets (ODTs) using a wet granulation tablet formation process. A drug entrapment efficiency of about 90% (w/w) and loading capacity of 20% (w/w) were achieved for the microparticles, which ranged from 2 μm to 8 μm in diameter. Results of disintegration tests showed that the formulated ODTs could be completely dissolved within 45 seconds. Drug dissolution profiles suggested that SH is released more slowly from tablets made using the microencapsulation process compared with tablets containing SH that is free or in the form of nanoparticles. The time it took for 90% of the drug to be released increased significantly from 3 minutes for conventional ODTs to 90 minutes for ODTs with crosslinked microparticles. Compared with ODTs made with noncrosslinked microparticles, it was thus possible to achieve an even lower drug release rate using tablets with appropriate chitosan crosslinking. Results obtained indicate that the development of new ODTs designed with crosslinked microparticles might be a rational way to overcome the unwanted taste of conventional ODTs and the side effects related to SH’s intrinsic characteristics. Dove Medical Press 2011 2011-04-28 /pmc/articles/PMC3124395/ /pubmed/21720502 http://dx.doi.org/10.2147/IJN.S17900 Text en © 2011 Li et al, publisher and licensee Dove Medical Press Ltd. This is an Open Access article which permits unrestricted noncommercial use, provided the original work is properly cited.
spellingShingle Original Research
Li, Feng-Qian
Yan, Cheng
Bi, Juan
Lv, Wei-Lin
Ji, Rui-Rui
Chen, Xu
Su, Jia-Can
Hu, Jin-Hong
A novel spray-dried nanoparticles-in-microparticles system for formulating scopolamine hydrobromide into orally disintegrating tablets
title A novel spray-dried nanoparticles-in-microparticles system for formulating scopolamine hydrobromide into orally disintegrating tablets
title_full A novel spray-dried nanoparticles-in-microparticles system for formulating scopolamine hydrobromide into orally disintegrating tablets
title_fullStr A novel spray-dried nanoparticles-in-microparticles system for formulating scopolamine hydrobromide into orally disintegrating tablets
title_full_unstemmed A novel spray-dried nanoparticles-in-microparticles system for formulating scopolamine hydrobromide into orally disintegrating tablets
title_short A novel spray-dried nanoparticles-in-microparticles system for formulating scopolamine hydrobromide into orally disintegrating tablets
title_sort novel spray-dried nanoparticles-in-microparticles system for formulating scopolamine hydrobromide into orally disintegrating tablets
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3124395/
https://www.ncbi.nlm.nih.gov/pubmed/21720502
http://dx.doi.org/10.2147/IJN.S17900
work_keys_str_mv AT lifengqian anovelspraydriednanoparticlesinmicroparticlessystemforformulatingscopolaminehydrobromideintoorallydisintegratingtablets
AT yancheng anovelspraydriednanoparticlesinmicroparticlessystemforformulatingscopolaminehydrobromideintoorallydisintegratingtablets
AT bijuan anovelspraydriednanoparticlesinmicroparticlessystemforformulatingscopolaminehydrobromideintoorallydisintegratingtablets
AT lvweilin anovelspraydriednanoparticlesinmicroparticlessystemforformulatingscopolaminehydrobromideintoorallydisintegratingtablets
AT jiruirui anovelspraydriednanoparticlesinmicroparticlessystemforformulatingscopolaminehydrobromideintoorallydisintegratingtablets
AT chenxu anovelspraydriednanoparticlesinmicroparticlessystemforformulatingscopolaminehydrobromideintoorallydisintegratingtablets
AT sujiacan anovelspraydriednanoparticlesinmicroparticlessystemforformulatingscopolaminehydrobromideintoorallydisintegratingtablets
AT hujinhong anovelspraydriednanoparticlesinmicroparticlessystemforformulatingscopolaminehydrobromideintoorallydisintegratingtablets
AT lifengqian novelspraydriednanoparticlesinmicroparticlessystemforformulatingscopolaminehydrobromideintoorallydisintegratingtablets
AT yancheng novelspraydriednanoparticlesinmicroparticlessystemforformulatingscopolaminehydrobromideintoorallydisintegratingtablets
AT bijuan novelspraydriednanoparticlesinmicroparticlessystemforformulatingscopolaminehydrobromideintoorallydisintegratingtablets
AT lvweilin novelspraydriednanoparticlesinmicroparticlessystemforformulatingscopolaminehydrobromideintoorallydisintegratingtablets
AT jiruirui novelspraydriednanoparticlesinmicroparticlessystemforformulatingscopolaminehydrobromideintoorallydisintegratingtablets
AT chenxu novelspraydriednanoparticlesinmicroparticlessystemforformulatingscopolaminehydrobromideintoorallydisintegratingtablets
AT sujiacan novelspraydriednanoparticlesinmicroparticlessystemforformulatingscopolaminehydrobromideintoorallydisintegratingtablets
AT hujinhong novelspraydriednanoparticlesinmicroparticlessystemforformulatingscopolaminehydrobromideintoorallydisintegratingtablets